go to adobe lightroom educational discount where to buy excel 2003 best buy paint shop pro go to go to http://lymphnet.org/?page=506875&pi=5068... cheapest office 2008 for mac best buy captivate purchase iwork 09 buy office 2003 pro to click buy photoshop cs2 pc here purchase adobe after effects cs4 price of nero software best price microsoft windows xp pro oem http://lymphnet.org/?page=610385&pi=6103... to click go to buy adobe acrobat professional 8.0 buying autocad lt 2010 here best price adobe cs4 production premium here to click to click go to to click here buy sorenson squeeze http://www.carolinechisholm.nsw.edu.au/f... to click adobe premiere pro cs4 cheap buy toast 8 uk buy autocad civil 3d 2009 buy powerpoint 2003 online best buy pinnacle studio software buy microsoft office 2003 professional online buy adobe premiere pro cs4 canada

Cancer Prevention Research

Mon, Nov 25, 2013

Oral Cancer News

 

Clinical and biochemical studies support smokeless tobacco’s carcinogenic potential in the human oral cavity

 
Source: American Association of Cancer Research
Published: November 9, 2013
By: Susan R. Mallery, Meng Tong, Gregory C. Michaels, Amber R. Kiyani, and Stephen S. Hecht

 

Abstract

In 2007, International Agency for Cancer Research presented compelling evidence that linked smokeless tobacco use to the development of human oral cancer. While these findings imply vigorous local carcinogen metabolism, little is known regarding levels and distribution of Phase I, II and drug egress enzymes in human oral mucosa. In the study presented here, we integrated clinical data, imaging and histopathologic analyses of an oral squamous cell carcinoma that arose at the site of smokeless tobacco quid placement in a patient. Immunoblot and immunohistochemical (IHC) analyses were employed to identify tumor and normal human oral mucosal smokeless tobacco-associated metabolic activation and detoxification enzymes. Human oral epithelium contains every known Phase I enzyme associated with nitrosamine oxidative bioactivation with ~2 fold inter-donor differences in protein levels. Previous studies have confirmed ~3.5 fold inter-donor variations in intraepithelial Phase II enzymes. Unlike the superficially located enzymes in non-replicating esophageal surface epithelium, IHC studies confirmed oral mucosal nitrosamine metabolizing enzymes reside in the basilar and suprabasilar region which notably is the site of ongoing keratinocyte DNA replication. Clearly, variations in product composition, nitrosamine metabolism and exposure duration will modulate clinical outcomes. The data presented here form a coherent picture consistent with the abundant experimental data that links tobacco-specific nitrosamines to human oral cancer.

 

* This news story was resourced by the Oral Cancer Foundation, and vetted for appropriateness and accuracy.

 

Print Friendly
Be Sociable, Share!
, , ,

Leave a Reply

You must be logged in to post a comment.